BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 66.6
- Dividend yield
- –
Brainsway Ltd. revenue by segment
By business segment
By product or service
By region
| Revenue | Q4 24 | Q4 23 | Q4 20 | Q4 19 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Europes [Member] | – | – | $335.00K | $461.00K | – | – |
| Other [Member] | – | – | $547.00K | $96.00K | – | – |
From the segment and revenue-disaggregation notes of Brainsway's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.